{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:25:22Z","timestamp":1792441522593,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fondazione Alessandro and Vincenzo Negroni Prati Morosini and Fondazione Romeo and Enrica Invernizzi."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01474-w","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:17:40Z","timestamp":1785259060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oligomeric Alpha-Synuclein from neural-derived extracellular vesicles as possible biomarkers of non-motor symptoms in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Mario","family":"Meloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Agliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Lea","family":"Saibene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Marano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Arcuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Zanzottera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca Rosa","family":"Guerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"1474_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1468-1331.2009.02900.x","volume":"17","author":"P Barone","year":"2010","unstructured":"Barone, P. Neurotransmission in Parkinson\u2019s disease: beyond dopamine. Eur. J. Neurol. 17, 364\u2013376 (2010).","journal-title":"Eur. J. Neurol."},{"key":"1474_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 18, 435\u2013450 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1474_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa, E., Garrido, A., Scholz, S. W. & Poewe, W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 20, 385\u2013397 (2021).","journal-title":"Lancet Neurol."},{"key":"1474_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s40263-013-0053-2","volume":"27","author":"F Sprenger","year":"2013","unstructured":"Sprenger, F. & Poewe, W. Management of motor and non-motor symptoms in Parkinson\u2019s disease. CNS Drugs 27, 259\u2013272 (2013).","journal-title":"CNS Drugs"},{"key":"1474_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2174\/1570159X20666221005090126","volume":"21","author":"PDE Weerasinghe-Mudiyanselage","year":"2023","unstructured":"Weerasinghe-Mudiyanselage, P. D. E., Kang, S., Kim, J.-S. & Moon, C. Therapeutic approaches to non-motor symptoms of Parkinson\u2019s disease: a current update on preclinical evidence. Curr. Neuropharmacol. 21, 560\u2013577 (2023).","journal-title":"Curr. Neuropharmacol."},{"key":"1474_CR6","doi-asserted-by":"publisher","first-page":"1257064","DOI":"10.3389\/fneur.2023.1257064","volume":"14","author":"M Filippi","year":"2023","unstructured":"Filippi, M., Balestrino, R. & Agosta, F. Editorial: biomarkers of non-motor symptoms in Parkinson\u2019s disease and parkinsonisms. Front. Neurol. 14, 1257064 (2023).","journal-title":"Front. Neurol."},{"key":"1474_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/1673-5374.264454","volume":"15","author":"C Agliardi","year":"2020","unstructured":"Agliardi, C. & Clerici, M. Blood extracellular vesicles (EVs) of central nervous system origin: a window into the brain. Neural Regen. Res. 15, 55\u201356 (2020).","journal-title":"Neural Regen. Res."},{"key":"1474_CR8","doi-asserted-by":"crossref","unstructured":"Yu, Y. et al. Central nervous system-derived extracellular vesicles as biomarkers in Alzheimer\u2019s disease. Int. J. Mol. Sci. 26, 8272 (2025).","DOI":"10.3390\/ijms26178272"},{"key":"1474_CR9","doi-asserted-by":"publisher","first-page":"105185","DOI":"10.1016\/j.nbd.2020.105185","volume":"148","author":"C Agliardi","year":"2021","unstructured":"Agliardi, C. et al. Oligomeric \u03b1-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson\u2019s disease. Neurobiol. Dis. 148, 105185 (2021).","journal-title":"Neurobiol. Dis."},{"key":"1474_CR10","doi-asserted-by":"publisher","first-page":"105947","DOI":"10.1016\/j.nbd.2022.105947","volume":"176","author":"M Meloni","year":"2023","unstructured":"Meloni, M. et al. Oligomeric \u03b1-synuclein and tau aggregates in NDEVs differentiate Parkinson\u2019s disease from atypical parkinsonisms. Neurobiol. Dis. 176, 105947 (2023).","journal-title":"Neurobiol. Dis."},{"key":"1474_CR11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/mds.25857","volume":"29","author":"GM Halliday","year":"2014","unstructured":"Halliday, G. M., Leverenz, J. B., Schneider, J. S. & Adler, C. H. The neurobiological basis of cognitive impairment in Parkinson\u2019s disease. Mov. Disord. 29, 634\u2013650 (2014).","journal-title":"Mov. Disord."},{"key":"1474_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1126\/science.1321498","volume":"257","author":"MK Bennett","year":"1992","unstructured":"Bennett, M. K., Calakos, N. & Scheller, R. H. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 257, 255\u2013259 (1992).","journal-title":"Science"},{"key":"1474_CR13","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1126\/science.1163174","volume":"321","author":"SH Gerber","year":"2008","unstructured":"Gerber, S. H. et al. Conformational switch of syntaxin-1 controls synaptic vesicle fusion. Science 321, 1507\u20131510 (2008).","journal-title":"Science"},{"key":"1474_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.neuroscience.2011.06.043","volume":"192","author":"D Yang","year":"2011","unstructured":"Yang, D. et al. Reduced neurogenesis and pre-synaptic dysfunction in the olfactory bulb of a rat model of depression. Neuroscience 192, 609\u2013618 (2011).","journal-title":"Neuroscience"},{"key":"1474_CR15","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1002\/cne.25155","volume":"529","author":"M Bieler","year":"2021","unstructured":"Bieler, M. et al. Changes in concentrations of NMDA receptor subunit GluN2B, Arc and syntaxin-1 in dorsal hippocampus Schaffer collateral synapses in a rat learned helplessness model of depression. J. Comp. Neurol. 529, 3194\u20133205 (2021).","journal-title":"J. Comp. Neurol."},{"key":"1474_CR16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neuroscience.2010.07.025","volume":"170","author":"MA Cervinski","year":"2010","unstructured":"Cervinski, M. A., Foster, J. D. & Vaughan, R. A. Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression. Neuroscience 170, 408\u2013416 (2010).","journal-title":"Neuroscience"},{"key":"1474_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jad.2018.04.053","volume":"235","author":"YJ Cao","year":"2018","unstructured":"Cao, Y. J., Wang, Q., Zheng, X. X., Cheng, Y. & Zhang, Y. Involvement of SNARE complex in the hippocampus and prefrontal cortex of offspring with depression induced by prenatal stress. J. Affect. Disord. 235, 374\u2013383 (2018).","journal-title":"J. Affect. Disord."},{"key":"1474_CR18","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1016\/j.ymthe.2021.04.035","volume":"29","author":"K Albert","year":"2021","unstructured":"Albert, K. et al. Cerebral dopamine neurotrophic factor reduces \u03b1-synuclein aggregation and propagation and alleviates behavioral alterations in vivo. Mol. Ther. J. Am. Soc. Gene Ther. 29, 2821\u20132840 (2021).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"1474_CR19","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1134\/S0006297921070063","volume":"86","author":"DV Eremin","year":"2021","unstructured":"Eremin, D. V., Ilchibaeva, T. V. & Tsybko, A. S. Cerebral Dopamine Neurotrophic Factor (CDNF): structure, functions, and therapeutic potential. Biochem. Biokhimiia 86, 852\u2013866 (2021).","journal-title":"Biochem. Biokhimiia"},{"key":"1474_CR20","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1474-4422(21)00219-2","volume":"20","author":"Y Sharabi","year":"2021","unstructured":"Sharabi, Y., Vatine, G. D. & Ashkenazi, A. Parkinson\u2019s disease outside the brain: targeting the autonomic nervous system. Lancet Neurol. 20, 868\u2013876 (2021).","journal-title":"Lancet Neurol."},{"key":"1474_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41592-021-01174-8","volume":"18","author":"M Norman","year":"2021","unstructured":"Norman, M. et al. L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat. Methods 18, 631\u2013634 (2021).","journal-title":"Nat. Methods"},{"key":"1474_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12459","volume":"13","author":"CJ Nogueras-Ortiz","year":"2024","unstructured":"Nogueras-Ortiz, C. J. et al. Single-extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron-derived EVs. J. Extracell. Vesicles 13, e12459 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"1474_CR23","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"1474_CR24","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","volume":"38","author":"ST Jost","year":"2023","unstructured":"Jost, S. T. et al. Levodopa dose equivalency in Parkinson\u2019s disease: updated systematic review and proposals. Mov. Disord. 38, 1236\u20131252 (2023).","journal-title":"Mov. Disord."},{"key":"1474_CR25","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.21596","volume":"22","author":"KR Chaudhuri","year":"2007","unstructured":"Chaudhuri, K. R. et al. The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: results from an international pilot study. Mov. Disord. 22, 1901\u20131911 (2007).","journal-title":"Mov. Disord."},{"key":"1474_CR26","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s10072-015-2278-y","volume":"36","author":"G Pierangeli","year":"2015","unstructured":"Pierangeli, G. et al. Translation and linguistic validation of the composite autonomic symptom score COMPASS 31. Neurol. Sci. 36, 1897\u20131902 (2015).","journal-title":"Neurol. Sci."},{"key":"1474_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns, M. W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14, 540\u2013545 (1991).","journal-title":"Sleep"},{"key":"1474_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R. & Kupfer, D. J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28, 193\u2013213 (1989).","journal-title":"Psychiatry Res."},{"key":"1474_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0013164402062004005","volume":"62","author":"L Barnes","year":"2002","unstructured":"Barnes, L., Harp, D. & Jung, W. Reliability generalization of scores on the spielberger state-trait anxiety inventory. Educ. Psychol. Meas. 62, 603\u2013618 (2002).","journal-title":"Educ. Psychol. Meas."},{"key":"1474_CR30","unstructured":"Beck Depression Inventory\u2013II. https:\/\/psycnet.apa.org\/doiLanding?doi=10.1037%2Ft00742-000"},{"key":"1474_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10072-016-2766-8","volume":"38","author":"G Santangelo","year":"2017","unstructured":"Santangelo, G. et al. Assessment of apathy independent of physical disability: validation of the Dimensional Apathy Scale in Italian healthy sample. Neurol. Sci. 38, 303\u2013309 (2017).","journal-title":"Neurol. Sci."},{"key":"1474_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10072-005-0443-4","volume":"26","author":"I Appollonio","year":"2005","unstructured":"Appollonio, I. et al. The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol. Sci. 26, 108\u2013116 (2005).","journal-title":"Neurol. Sci."},{"key":"1474_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1155\/1995\/304876","volume":"8","author":"F Mahieux","year":"1995","unstructured":"Mahieux, F. et al. Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson\u2019s disease. Behav. Neurol. 8, 15\u201322 (1995).","journal-title":"Behav. Neurol."},{"key":"1474_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10072-014-1995-y","volume":"36","author":"G Santangelo","year":"2015","unstructured":"Santangelo, G. et al. Normative data for the montreal cognitive assessment in an Italian population sample. Neurol. Sci. 36, 585\u2013591 (2015).","journal-title":"Neurol. Sci."},{"key":"1474_CR35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub, D. et al. Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease-rating scale. Mov. Disord. 27, 242\u2013247 (2012).","journal-title":"Mov. Disord."},{"key":"1474_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer, D. I. et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J. Neuropsychiatry Clin. Neurosci. 12, 233\u2013239 (2000).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"1474_CR37","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton, J. H., Stanford, M. S. & Barratt, E. S. Factor structure of the Barratt impulsiveness scale. J. Clin. Psychol. 51, 768\u2013774 (1995).","journal-title":"J. Clin. Psychol."},{"key":"1474_CR38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fnins.2017.00278","volume":"11","author":"M Mustapic","year":"2017","unstructured":"Mustapic, M. et al. Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes. Front. Neurosci. 11, 278 (2017).","journal-title":"Front. Neurosci."},{"key":"1474_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"1474_CR40","doi-asserted-by":"publisher","first-page":"e57221","DOI":"10.1371\/journal.pone.0057221","volume":"8","author":"K Ray Chaudhuri","year":"2013","unstructured":"Ray Chaudhuri, K. et al. A proposal for a comprehensive grading of Parkinson\u2019s disease severity combining motor and non-motor assessments: meeting an unmet need. PloS ONE 8, e57221 (2013).","journal-title":"PloS ONE"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01474-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01474-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01474-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:43:02Z","timestamp":1787733782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01474-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1474"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01474-w","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"203"}}